Moteur de recherche d’entreprises européennes
Financement de l’UE (899 995 €) : Mise en réseau améliorée de la surveillance de la résistance aux antimicrobiens grâce au séquençage de nouvelle génération Hor14/07/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Mise en réseau améliorée de la surveillance de la résistance aux antimicrobiens grâce au séquençage de nouvelle génération
Our project “Enhanced networking on antimicrobial resistance surveillance with NGS” brings together Semmelweis University (SU) and Klinika Za Infektivne Bolesti „Dr. Fran Mihaljevic (BFM) with two internationally leading research institutions, Laboratory of Medical Microbiology (LMM), University of Antwerp (UAntwerp) and the Health Research Institute of the Balearic Islands (IdISBa) , on the topic of Antimicrobial resistance surveillance with whole genome sequencing (WGS) in correlation next-generation sequencing techniques. Our aim in AmReSu is to strengthen, to the highest European level, Semmelweis University (SU)’s and Klinika Za Infektivne Bolesti „Dr. Fran Mihaljevic” (BFM)’s scientific excellence and innovation capacity in Antimicrobial resistance surveillance and to set-up an ‘Antimicrobial resistance surveillance vision’ in Hungary and Croatia. Strenghtening antimicrobial resistance (AMR) surveillance is also in line with the Hungarian National Smart Specialisation Strategy and the Croatian National Programe for Antibiotic Resistance Control. AMR bacterial infections are a global threat, they are responsible for increased morbidity and mortality rates in Hungary and Croatia, especially in cases of nosocomial infection. Many previously manageable bacterial infections are becoming increasingly hard to treat. Rising rates of resistance amplify the morbidity and economic burden associated with infections. An estimated 700,000 deaths attributable to AMR every year in the world, and a projected 10 million deaths per year by 2050 in the absence of additional control measures. The core activities of our project are knowledge transfer, exchanges of best practices via a number of institutional networking and training activities, including workshops, conferences, summer schools. to a new level, promoting research excellence in AMR and Microbiome with strong societal impact. Our proposed actions will strengthen joint research programmes in Europe.
| Fundacio Institut D'Investigacio Sanitaria Illes Balears | 150 363 € |
| KLINIKA ZA INFEKTIVNE BOLESTI DR. FRAN MIHALJEVIC | 173 928 € |
| Semmelweis Egyetem | 264 830 € |
| Universiteit Antwerpen | 310 875 € |
https://cordis.europa.eu/project/id/952491
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "Fundacio Institut D'Investigacio Sanitaria Illes Balears - Financement de l’UE (899 995 €) : Mise en réseau améliorée de la surveillance de la résistance aux antimicrobiens grâce au séquençage de nouvelle génération"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
